TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells
Purpose Invasion of cancer cells depends on the proteolytic degradation of extracellular matrix regulated by actin-driven membrane protrusions, called invadopodia. However, the mechanisms underlying invadopodia formation in cancer cells remain largely unknown. Methods By employing adenoviral transdu...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and clinical oncology 2013-10, Vol.139 (10), p.1657-1665 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
Invasion of cancer cells depends on the proteolytic degradation of extracellular matrix regulated by actin-driven membrane protrusions, called invadopodia. However, the mechanisms underlying invadopodia formation in cancer cells remain largely unknown.
Methods
By employing adenoviral transduction of breast cancer cells with either β-galactosidase (Ad-LacZ) or TIS21
/BTG2/Pc3
(Ad-TIS21) gene, the regulation of invadopodia formation was investigated. Invasion activity was examined by invadopodia assay and Matrigel assay. Intracellular reactive oxygen species (ROS) was monitored by FACS-based analysis.
Results
Here, we observed that TIS21 suppressed invadopodia formation as well as invasion activity along with F-actin remodeling. The inhibition of TIS21-mediated invadopodia formation was accompanied with attenuation of ROS generation in the TIS21 expressers, indicating that TIS21-mediated inhibition of ROS plays a critical role for invadopodia formation by regulating actin-associated protein remodeling. This was further confirmed in the TIS21
−/−
MEF cells.
Conclusions
This is the first report to provide insight into invasion signals regulated by tumor suppressor, TIS21
/BTG2/Pc3
gene, in the intractable breast cancer cells. |
---|---|
ISSN: | 0171-5216 1432-1335 |
DOI: | 10.1007/s00432-013-1484-3 |